Consensus AB Science

Equities

AB

FR0010557264

Market Closed - Euronext Paris Other stock markets 11:35:29 2024-05-03 am EDT			5-day change	1st Jan Change
1.97 ^EUR	+3.79%		+1.76%	-44.59%

May. 03	AB Science: upbeat after legal success	CF
May. 03	French Appeals Court Acquits AB Science CEO of Insider Trading Charges	MT

Evolution of the average Target Price on AB Science

Price target over the last 5 years

History of analyst recommendation changes

534f739d3445b7203b2ee.NEgJ2V45goRg-5aZvmoMP9ckG_EdJxDjRL8-bf7DTno.dyBk6jJj-9sWuKXr-lNofZNIWaNETCKGPv1ZHce6Dy9zG3yYZ2razFjM3w~c14f4da128cb26f57f94ab4d27131e72

Analyst Recommendations on AB Science

AB Science : Masitinib Treatment Against Pancreatic Cancer Boosts Survival Rates	20-12-04	MT
SCIENCE : AB Science: Chardan Capital Markets initiates coverage with a BUY recommendation on AB Science and a target price of €30	15-05-05	GL

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.97 EUR

Average target price

6.895 EUR

Spread / Average Target

+250.00%

High Price Target

10 EUR

Spread / Highest target

+407.61%

Low Price Target

3.79 EUR

Spread / Lowest Target

+92.39%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar